340267-36-9 Usage
Uses
Used in Pharmaceutical Industry:
Isoxazole, 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)is used as a pharmaceutical compound for its potential medicinal properties. Its unique molecular structure allows it to interact with biological targets, making it a candidate for the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical field, Isoxazole, 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)is used as a chemical intermediate for the synthesis of agrochemicals. Its specific reactivity and properties can be harnessed to create effective pesticides or other agricultural products.
Used in Materials Science:
Isoxazole, 3-[4-(methylsulfonyl)phenyl]-4-phenyl-5-(trifluoromethyl)is utilized in materials science for the development of new materials with specific properties. Its molecular structure can contribute to the creation of materials with tailored characteristics for various applications, such as high-performance polymers or advanced materials for electronics.
Note: The uses listed are hypothetical and based on the compound's unique structure and properties. Actual applications may vary and would require further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 340267-36-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,0,2,6 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 340267-36:
(8*3)+(7*4)+(6*0)+(5*2)+(4*6)+(3*7)+(2*3)+(1*6)=119
119 % 10 = 9
So 340267-36-9 is a valid CAS Registry Number.
340267-36-9Relevant academic research and scientific papers
Majo, Vattoly J.,Prabhakaran, Jaya,Simpson, Norman R.,Van Heertum, Ronald L.,Mann, J. John,Kumar, J. S. Dileep
, p. 4268 - 4271 (2005)
A general one-pot method has been developed for the conversion of an aryl thiol moiety masked as the butyrate ester to the corresponding 11C-labeled methylsulfone group. The potential of this methodology has been demonstrated by the successful radiosynthesis of carbon-11 analogues of several highly selective cyclooxygenase-2 (COX-2) inhibitors such as Rofecoxib, Etoricoxib, and 3-(4-methylsulfonylphenyl)-4-phenyl-5-trifluoromethyl isoxazole in high yield. The chemical and radiochemical purities obtained for the 11C-labeled COX-2 inhibitors are >99% with a specific activity >1000 Ci/mmol.
